MGC Pharmaceuticals (ASX:MXC) Share Price and News

Market Cap (29-Apr) $18,417,672 (949th)	Close (30-Jun) $0.005 0 (0%)	Volume (30-Jun) 14,697,042	Shortsold (2-Apr) 218 (0.00%) (630th)
52w High $9.00	52w Low $0.300	P/E 14.90	EPS -3.21

	Subject
	MXC MXC Ann: Details of Company Address
	1 (current) 2 3
	MXC MXC Ann: Company Update
	MXC MXC Ann: Results of Meeting
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Final Director's Interest Notice x 2
	MXC MXC Ann: Initial Director's Interest Notice
	MXC MXC Ann: Appointment of Non-Executive Director
	MXC MXC Ann: First CannEpil Delivered to UK Patients
	MXC MXC Ann: Corporate Update - Board and UK Adviser Changes
	MXC MXC Ann: Notice of General Meeting/Proxy Form
	MXC MXC Ann: Distribution of General Meeting Documents - Notice of Access
	MXC MXC Ann: Change in Director's Interests x 5
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: Notification of cessation of securities - MXC
	MXC MXC Ann: Malta Production Facility Receives EU-GMP Approval
	MXC MXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Becoming a substantial holder
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Fundraise closed raising up to a total of GBP 2.09m
	MXC MXC Ann: CannEpil now available by Named Patient Request in UK
	MXC MXC Ann: MGC Pharma Investor Presentation April 2023
	MXC MXC Ann: Funding Commitments Received for GBP 1.8m
	MXC MXC Ann: Trading Halt
	MXC MXC Ann: MGC Receive Permission for Psilocybin Research & Development
	MXC MXC Ann: Notification of cessation of securities - MXC
	MXC MXC Ann: Results of Meeting
	MXC MXC Ann: ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
	MXC MXC Ann: First patient enrolled in MGC ZAM App CannEpil Trial
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: Provision of US$500,000 Funding
	MXC MXC Ann: s708A(12C)(e) Cleansing Notice
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Completion of CimetrA Mechanism of Action study
	MXC MXC Ann: Appointment of UK Lead Broker Change of Company Secretary
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Half Year Accounts
	MXC MXC Ann: Notice of General Meeting/Proxy Form
	MXC MXC Ann: Distribution of General Meeting Documents - Notice of Access
	MXC MXC Ann: Investor Presentation

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.42	6,035	0.00 (0.00%)
26-Apr	$0.42	1,033	+0.01 (2.47%)
24-Apr	$0.41	6,603	-0.03 (5.81%)
23-Apr	$0.43	0	0.00 (0.00%)
22-Apr	$0.43	5,109	0.00 (0.00%)
19-Apr	$0.43	4,257	0.00 (0.00%)
18-Apr	$0.43	0	0.00 (0.00%)
17-Apr	$0.43	2	-0.01 (1.15%)
16-Apr	$0.44	18,828	-0.01 (2.25%)
15-Apr	$0.45	11,403	0.00 (0.00%)
12-Apr	$0.45	49,208	+0.01 (2.30%)
11-Apr	$0.44	8,542	+0.02 (4.82%)
10-Apr	$0.42	6,145	-0.02 (3.49%)
09-Apr	$0.43	43,411	+0.02 (3.61%)
08-Apr	$0.42	27,077	+0.01 (1.22%)
5 up, 4 down, and 6 flat days

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

MGC Pharmaceuticals Health Care

$0.005 (0%)

$0.005 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices